SCHEMBL3758247

SCHEMBL3758247

CC(C)(C)OC(=O)NCCCCCCNC(=O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2CS1(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
CYP3A4 P08684 1/20 0.40
PLCD1 P51178 1/20 0.39
DRD2 P14416 1/20 0.39
TPSAB1 Q15661 2/20 0.38
F2 P00734 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
PSEN1 P49768 2/20 0.37
PSEN2 P49810 2/20 0.37
APH1B Q8WW43 2/20 0.37
NCSTN Q92542 2/20 0.37
APH1A Q96BI3 2/20 0.37
PSENEN Q9NZ42 2/20 0.37
ITGB1 P05556 1/20 0.37
ITGA4 P13612 1/20 0.37
CNR1 P21554 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049595 1.00 TDP1 (0.42) TDP1CYP3A4PLCD1DRD2TPSAB1
SCHEMBL20123249 1.00 TDP1 (0.42) TDP1CYP3A4PLCD1DRD2TPSAB1
SCHEMBL4962526 0.86 TDP1 (0.50) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL19751702 0.85 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL4965653 0.85 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL18501099 0.85 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL3758250 0.84 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL13080217 0.84 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL13049592 0.84 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1
SCHEMBL13049465 0.84 TDP1 (0.48) TDP1PLCD1TPSAB1F2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 EP disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 TDP1 118/4885CYP3A4 387/4885PLCD1 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.